Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3M5L

Crystal structure of HCV NS3/4A protease in complex with ITMN-191

3M5L の概要
エントリーDOI10.2210/pdb3m5l/pdb
関連するPDBエントリー3M5M 3M5N 3M5O
分子名称NS3/4A, (2R,6S,12Z,13aS,14aR,16aS)-6-[(tert-butoxycarbonyl)amino]-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8 ,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoro-2H-isoindole-2-carboxylate, SULFATE ION, ... (5 entities in total)
機能のキーワードhcv, hepatitis c virus, ns3, protease, drug resistance, serine protease, chimera protein, fusion protein, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Hepatitis C virus subtype 1a (HCV)
詳細
細胞内の位置Virion : A8DG50
タンパク質・核酸の鎖数1
化学式量合計22378.62
構造登録者
Schiffer, C.A.,Romano, K.P. (登録日: 2010-03-12, 公開日: 2010-11-24, 最終更新日: 2024-02-21)
主引用文献Romano, K.P.,Ali, A.,Royer, W.E.,Schiffer, C.A.
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.
Proc.Natl.Acad.Sci.USA, 107:20986-20991, 2010
Cited by
PubMed Abstract: Hepatitis C virus infects an estimated 180 million people worldwide, prompting enormous efforts to develop inhibitors targeting the essential NS3/4A protease. Resistance against the most promising protease inhibitors, telaprevir, boceprevir, and ITMN-191, has emerged in clinical trials. In this study, crystal structures of the NS3/4A protease domain reveal that viral substrates bind to the protease active site in a conserved manner defining a consensus volume, or substrate envelope. Mutations that confer the most severe resistance in the clinic occur where the inhibitors protrude from the substrate envelope, as these changes selectively weaken inhibitor binding without compromising the binding of substrates. These findings suggest a general model for predicting the susceptibility of protease inhibitors to resistance: drugs designed to fit within the substrate envelope will be less susceptible to resistance, as mutations affecting inhibitor binding would simultaneously interfere with the recognition of viral substrates.
PubMed: 21084633
DOI: 10.1073/pnas.1006370107
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.25 Å)
構造検証レポート
Validation report summary of 3m5l
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon